plenty of doubting Thomases out there mate, they won’t believe till they can see it, and even after seeing, they’ll need to touch it
The violent wake up point will be when Mr Market realizes the distinction between general medicine vs precision medicine. It’ll start scrambling for the correct probability parameters to assign to PYC’s pipeline of pre-clinical leads, and might then start digging deeper to our patent pipeline.
This is where us on this thread differ from the general population in that we’re roughly a year ahead of the story arc; I love the IMU story, but PYC playing in the RNA precision medicine space provides a totally different upshot potential
plenty of doubting Thomases out there mate, they won’t believe...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.8¢ |
Change
-0.003(1.92%) |
Mkt cap ! $606.5M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 13.5¢ | 12.5¢ | $12.66K | 97.75K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 1302598 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 1139369 | 8 |
View Market Depth
| Last trade - 14.24pm 05/07/2024 (20 minute delay) ? |
| PYC (ASX) Chart |